Skip to main content

Table 1 Characteristics of the patients

From: Outcomes of tricuspid annuloplasty with and without prosthetic rings: a retrospective follow-up study

Characteristic Annuloplasty without ring (De Vega procedure) (n = 34) Annuloplasty with ring (n = 40) P value
Age (yr ± SD) 47.2 ± 7.3 49.5 ± 8.7 0.241
Male 7 20.6 % 4 10.0 % 0.326
Preoperative NYHA ClassIII-IV 33 97.1 % 38 95.0 % 0.945
Preoperative TI grade      
None (n) 0 0.0 % 0 0.0 % 0.131
Mild (n) 8 23.5 % 14 35.0 %
Moderate (n) 18 52.9 % 23 57.5 %
Severe (n) 8 23.5 % 3 7.5 %
Preoperative TS 0 0 0 0  
Preoperative mitral valve disease      
None (n) 0 0.0 % 0 0.0 % 0.808
Stenosis (n) 21 61.7 % 24 60.0 %
Insufficiency (n) 2 5.8 % 4 10.0 %
Stenosis and insufficiency (n) 11 32.4 % 12 30.0 %
Preoperative aortic valve disease      
None (n) 17 50.0 % 21 52.5 % 0.98
Stenosis (n) 1 2.9 % 1 2.5 %
Insufficiency (n) 7 20.6 % 9 22.5 %
Stenosis and insufficiency (n) 9 26.5 % 9 22.5 %
Preoperative      
LVEF 55.9 ± 9.1 58.1 ± 7.1 0.253
RVD 22.9 ± 5.1 21.9 ± 3.4 0.29
LVD 49.6 ± 6.66 47.9 ± 8.8 0.351
PASP 51.5 ± 16.6 49.9 ± 14.2 0.668
1 year Postoperative      
LVEF 61.9 ± 10.0 61.0 ± 8.8 0.733
RVD 20.7 ± 2.9 20.0 ± 2.2 0.277
LVD 44.5 ± 5.6 45.6 ± 4.1 0.37
PASP 36.5 ± 7.4 36.0 ± 8.3 0.903
Concomitant procedures      
MVR (n) 22 64.7 % 32 80.0 % 0.132
AVR (n) 0 0 0 0
MVR + AVR (n) 12 35.3 % 8 20.0 %
  1. AVR aortic valve replacement, LVEF left ventricular ejection fraction, LVD left ventricular diameter, RVD right ventricular diameter, MVR mitral valve replacement, NYHA New York Heart Association, PASP pulmonary arterial systolic pressure, SD standard deviation, TI tricuspid valve insuffiency, TS tricuspid valve stenosis